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ABSTRACT  
Objective: The aim of this study was to formulate and evaluate a taste-masked formulation using hot melt extrusion approach for artemether. 
Methods: Taste masking of artemether was done by preparing solid dispersion with coating polymer kollicoatsmartseal 30D using hot melt extrusion. The 
prepared solid dispersion was subjected to taste masking evaluation like sensory evaluation parameters against five levels set for taste evaluation using 
artemether as control standard along with in vitro release studies in simulated salivery fluid. After taste evaluation of solid dispersion was subjected to the 
formulation of dispersible tablets by direct compression method. The final taste masking evaluation of dispersible tablets of solid dispersion containing 
artemether were done by a sensory evaluation panel of nine members along with in vitro release study in simulated salivary and gastric fluid. 
Results: The percent drug content was found 35.09±0.06 % in solid dispersion. The drug excipients compatibility studies performed with the help 
of FTIR instrument and DSC that indicates there were no interactions between drug and polymers. Solid dispersions (1:1, 1:2, 1:3 drug polymer 
ratio) of artemether were evaluated by sensory evaluation panel from which 1:3 drug: polymer solid dispersion was found more palatable. Release 
rate study in simulated salivary fluid shown no release but shows release of drug in simulated gastric fluids which indicates that the drug was taste 
masked. The optimized batch of dispersible tablets (F1) were subjected for evaluation parameters like dispersion time (70±1.90), wetting time 
(63±1.86), etc. Dissolution studies of optimized formulation indicated that the polymer does not allow drug to release in simulated salivery pH 6.8 
but shows immediate release in simulated gastric pH which also confirms taste masking efficiency of polymer. Final optimized F1 batch evaluated 
for taste masking evaluation by sensory evaluation panel using pure drug as control standard found to be palatable.  
Conclusion: It may be concluded that kollicoatsmartseal 30D could mask the taste of the drug in salivary pH and shows drug release at gastric pH 
which confirms its efficiency for taste masking. 
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Worst the taste of the medication, the better the cure was once the 
prevailing attitude. Today this trend has changed and great 
importance is placed on the organoleptic characteristics of 
pharmaceutical products [1]. Oral administration of pharmaceuticals 
is one of the most popular method of drug delivery [2]. Organoleptic 
characteristics of pharmaceutical products, i.e. Taste, odor, and 
appearance are essential factors in assessing the patient acceptability; 
out of these organoleptic characteristics of taste is an important 
parameter governing patient compliance [3]. Some active 
pharmaceutical ingredients (API's) are generally associated with an 
unpleasant taste. The formulations containing such APIs are poorly 
accepted by patients and the adherence to treatment is adversely 
affected. Bad taste is a primary barrier while administering drugs to 
children. Most of the pediatricians reported that the taste and 
palatability were the greatest hurdles to complete treatment. 
Therefore. It is necessary to discover robust approaches to formulate 
the dosage forms to mask the unpleasant taste of the API to improve 
the ease of administration and palatability. Oral administration of 
bitter drugs with an acceptable degree of palatability is a key issue for 
health care providers, especially for pediatric patients. Taste masking 
in the present day pharmaceutical industry has become a potential 
tool to improve patient compliance and commercial success of the 
product [3-6]. The taste of any substance can be improved by two 
basic manipulations; either by reducing the drug solubility or by 
altering the ability of the drug to interact with taste receptors [7]. 
Artemether (ARM) drug used for the prevention of malaria and is 
included in the WHO list of essential medicines. Artemether is 
essential for rapid clearance of parasitemia and rapid resolution of 
symptoms. It reduces parasite numbers by a factor of approximately 
10,000 in each asexual cycle, which is more than other current 
antimalarial (which reduce parasite numbers 100–1000-fold per 
cycle). Artemether is active against P. vivax as well as chloroquine 
sensitive and chloroquine resistant strains of P. falciparum and is 
also indicated in the treatment of cerebral malaria [8-12]. 
The objective of this study was to developed taste masked formulation of 
artemether which is intensely bitter in taste and is a critical problem, 
especially in the pediatric population. Hence, to increase the palatability 
of the drug it is necessary to mask the taste and to formulate a suitable 
dosage form to enhance patient compliance and adherence to treatment. 
On this background, this research was designed to address the question, 
whether it is possible to mask the intensely bitter taste of the poorly 
water soluble drug ‘Artemether’ by hot melt extrusionusing the 
kollicoatsmartseal 30D as a polymer for taste abatement? 
Oro-dispersible tablets (ODTs) entered the market in the 1980s as 
an alternative to tablets and it also provides an advantage 
particularly for pediatric and geriatric populations who have 
difficulty in swallowing conventional tablets and capsules
MATERIALS AND METHODS 
 [13]. 
Materials 
Artemether was received as a gift sample from ajanta pharma 
limited. aurangabad and IPCA laboratories limited. ratlam, India. 
kollicoatsmartseal 30 D was received as a gift sample from the BASF 
chemical company, mumbai, India. Potassium dihydrogen phosphate 
procured from modern Scientifics, nashik-India. Materials were used 
as received. 
Methods 
Preparation of drug: polymer solid dispersion by hot melt 
extrusion (HME)  
The HME was optimized by trial and error method with the help of 
data obtained from previous work. It was optimized first using 
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several parameters like inlet and outlet temperature (50-60 °c) the 
batches were taken as placebo, drug: polymers in various ratios (1:1, 
1:2, and 1:3). Weigh drug and polymer in 1:1 ratio and prepared 
granules for the further process before HME. Likewise, all the 
batches of prepared granules of drug: polymer (1:1, 1:2 and 1:3) was 
hot melt extruded [14-16]. 
Characterization of drug-polymer dispersion 
Percent drug contained in drug: polymer dispersion 
The percentage of drug complexes with polymer was determined by 
using HPLC analysis. With a stainless steel column 25 cm X 4.0 mm, 
packed with octadecylsilane bonded to porous silica (5 µm), Mobile 
phase: a mixture of 62 volumes of acetonitrile, 38 volumes of water, 
Flow rate1.5 ml per minute, Injection volume 20 µl, Spectro-
photometer set at 216 nm. 
Attenuated total reflectance spectroscopy (ATR) 
Spectra of the drug-polymer dispersion were recorded using Bruker 
Eco-ATR machine. The spectra were scanned over the wave number 
range of 3600 to 400 cm–1. 
The release of the drug (artemether) from drug-polymer complexes 
were studied at the pH of the mouth (simulated salivary fluid) pH 
6.8, To determine the amount of the drug that would be released in 
the mouth during the administration of the formulation. The 
bitterness of the taste is related to the amount of drug released in 
the mouth, a plain drug was used as a control. In brief the dispersion 
was accurately weighed (equivalent to 80 mg) and added to 5 ml 
simulated salivary fluid pH 6.8 placed in the test tube. An aliquot 
was withdrawn after an interval of 1 min. The sample was filtered 
and absorbance was measured of Artemether at 216.0 nm. The drug 
concentration in the sample was determined from the standard 
curve of the drug in simulated salivary fluid (pH 6.8). The reported 
values of percent drug release are average values of three readings.  
ATR was done for pure drug samples and 
for the drug: polymer dispersion. 
Differential scanning calorimetry (DSC) 
Differential scanning calorimetry (DSC) was performed using 
METTLER calorimeter to study the thermal behavior of dispersion 
formed and compare it with the DSC curve of the drug sample.  
In vitro release study 
Release rate study of drug: polymer dispersion 
Release rate study at simulated gastric pH 
The release rate of the drug and drug: polymer dispersions were 
studied at gastric pH in simulated gastric fluid and 0.1 N HCl with 
the help USP dissolution test apparatus II (model: disso 2000 
apparatus: labindia). Solid drug: polymer dispersions were weighed 
accurately and subjected to release rate study. Parameters were set 
as 75rpm, temperature 37 °c, media volume 900 ml. 10 ml of the 
aliquot was withdrawn at specific time interval as per requirement 
and maintained sink condition by adding the same volume of fresh 
dissolution medium. Each of the 10 ml samples was filtered. The 
drug concentration in the sample was determined from the standard 
curve of the artemether in 0.1 N HCl (213.00). The reported values 
of percent drug release are average values of three readings.  
Taste evaluation of solid drug: polymer dispersion  
The sample of each drug: polymer complex was subjected to sensory 
evaluation by a panel of nine members With respect to bitter taste. 
The pure drug was used as a control having an average bitterness 
value of 5. Bitterness values were categorized into 5 levels with 
respect to the bitterness of artemether were at level 5: very strongly 
bitter, level 4: strongly bitter, level 3: moderately bitter taste, level 2: 
palatable, level 1: no bitter taste [18]. 
Formulation and development of dispersible tablet  
Dispersible tablets were prepared by using the solid drug: polymer 
dispersion (1:3) of artemether with kollicoatsmartseal 30 D. The 
dispersion was taken equivalent to doses of the drug. Four different 
types of dispersible tablets were formed using a different type of 
super-disintegrating agents by direct compression method using 10 
stations compression machine (REMEK) by using an Oval shape 
punch of size 10. These super disintegrating agents are 
crospovidone and sodium starch glycollate. The formulations were 
coded as formulation F1, F2, F3 and F4 respectively. The 
composition of formulation batches F1, F2, F3, F4 were shown in 
table 2. 
 
Table 2. Selected prototype for dispersible tablet preparation 
Ingredients Quantity of ingredients (mg) 
F2 F1 F3 F4 
Artemether 200 200 200 200 
Sodium starch glycolate 40 30 30 40 
PVPK30 15 15 10 10 
Mannitol 63 73 78 68 
Microcrystalline cellulose 80 80 80 80 
Magnesium stearate 2 2 2 2 
Flavor QS QS QS QS 
Total 400 400 400 400 
F1, F2, F3 and F4 were formulations code. PVPK30-polyvinylpyrrolidone K30, QS-Quantity sufficient 
 
Evaluation of dispersible tablet 
Parameters were evaluated for tablets at, dispersion time, wetting 
time, wetting volume and uniformity of dispersion 
Taste evaluation of dispersible tablet 
The sample of each dispersible tablet was subjected to sensory 
evaluation by a panel of nine members with respect to bitter taste 
standards (pure drug-artemether). 
Release rate study of the formulation 
The release rate study of the tablets in 0.1N HCl was carried out 
using USP II apparatus in 900 ml dissolution media at 75 RPM, to 
determine the amount of drug that would be released in the stomach 
after administration of the tablet. The release rate of optimized 
formulation also carried out in simulated salivary pH 6.8. 
RESULTS AND DISCUSSION  
Percent drug contained in drug: polymer dispersion 
The drug content in the dispersion was calculated using 
comparisons of an area of peaks obtained by HPLC method. 20 ppm 
concentration of dispersion shown 35.09±0.06 % drug content with 
respect to 20 ppm concentration of pure drug (artemether). 
Chromatograms were shown in fig. 1. The results indicates sufficient 
amount of drug entrapped in polymer [24]. 
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Fig. 1: (a) Is chromatogram of artemether and (b) is a chromatogram of dispersion 
 
Attenuated total reflectance spectroscopy (ATR) 
The characteristic peaks of ARM at 2930.13 cm-1 are assigned to C–H 
stretching vibration in CH3, CH2. In addition, the absorption peak at 
1448.02 cm-1 can be assigned to C–H bending vibration in C–O–CH3. 
The peak at 1019 cm-1 can be assigned to C–O stretching, vibration 
in, C–O–C. The peaks at 1103.81is assigned to C–O stretching in with 
low intensity. The peak at 3670. 38 cm-1
 
indicates O-H stretching due 
to a little amount of moisture may present. All the above 
characteristic peaks of ARM appear in the spectra of the binary 
system, i.e. Solid dispersion at same wavenumber with a little shift 
in peaks indicating no modification or interaction between the drug 
and polymer. ATR spectra shown in fig. 2. It indicates that the drug 
and polymer were compatible with each other. 
 
Fig. 2: (a) Is ATR spectra of artemether and (b) ATR spectra of dispersion 
 
Differential scanning calorimetry (DSC) 
Thermal behavior of pure drug and corresponding drug dispersion 
system are depicted in fig. 3. The pure ARM shows a sharp 
endothermic peak at 88.08 °C, followed by an exothermic peak at 
183.04 °C. The characteristic endothermic peak corresponding to 
the melting peak of ARM was shifted towards lower temperature, 
with reduced intensity in solid dispersions. This could be 
attributed to higher polymer concentration and uniform 
distribution of ARM in the crust of polymer, resulting in complete 
miscibility of the molten drug in a polymer. Moreover, the data 
also indicate there seems to be no interaction between the 
components of the binary system. 
In vitro release study 
Release rate study of drug: polymer dispersion 
The dispersion shows no drug release in phosphate buffer pH 6.8 
compared with that of pure drugs. As the polymer does not dissolve 
above pH 6.8 it will not release the drug in the buffer that means 
drug not directly come in contact with the taste buds and hence 
gives prior idea about taste abatement was done or not [26]. 
Release rate study at simulated gastric pH 
The increase in dissolution profile was observed when drug releases 
of batches 1:1, 1:2, 1:3 was compared with that of pure drugs. The 
reason behind this could be various instrumental factors like use of 
hot melt extruder. Percent cumulative drug release in 60 min. Shown 
as pure drug 32.53 (±0.27), batches 1:1, 1:2, 1:3 shows 45.27 (±0.88), 
45.59 (±0.55), 43.97 (±0.37) respectively. Percent cumulative drug 
release comparison is shown in fig. 4.  
Release study in simulated gastric pH confirms that the polymer release 
drug quickly in acidic media and make drugs available at the site of 
absorption which is in stomach without any delaying in drug release 
from polymeric entrapment. The release rate study also confirms the 
property of polymer. Kollicoatsmartseal 30 D does not allow dispersion 
of drug to release drugs into simulated salivary phosphate buffer pH 6.8, 
but quickly release the drug in simulated gastric fluid [29]. 
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Fig. 3: (a) Is thermogram of artemether and (b) is a thermogram of dispersion 
 
 
Fig. 4: Percent cumulative drug release (n=3, Data presented as mean±SD) 
 
Taste evaluation of solid drug: polymer dispersion 
The drug: polymer dispersion ratio 1:1, 1:2 and 1:3were 
evaluated against the pure drug by a sensory evaluation panel of 
nine members. The drug dispersion ratio 1:3 shows the 
bitterness value score 1.44 which is close to level 1 that is 
palatable and other dispersions were failing to mask bitterness 
as compared with 1:3 drug polymer ratio. Hence this dispersion 
was selected for the formulation of dispersible tablet. Sensory 
evaluation data shown in table 1. Results shown that polymer 
masks the bitterness of API by means of forming a coating 
around drug molecules [18, 26, 28-29]. 
 
Table 1: Sensory evaluation data of solid dispersion 
Ratio of drug: polymer dispersion Scores of drug: polymer dispersion Average bitterness value 
Group II Group I Group III 
Pure drug 5 5 5 5 5 5 5 5 5 5 
1:1 2 3 3 2 4 3 2 4 3 2.88 
1:2 2 1 2 2 1 1 3 2 1  1.66 
1:3 1 2 1 1 2 2 1 2 1 1.44 
 
Evaluation of formulation: dispersible tablet 
After taste evaluation, drug polymer ratio 1:3 was selected for 
dispersible dosage form preparation. Dispersible tablets were 
evaluated against dispersion time, wetting time, wetting volume and 
uniformity of dispersion. After characterization of tablets F1 batch 
formulation was selected as best formulation compared with other 
batches of formulation. Evaluation parameters were shown in table 3.
Sonar et al. 
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Table 3: Evaluation of formulations 
S. No. Evaluation parameter Formulations (*±SD) 
F2 F1 F3 F4 
1 Dispersion time (Sec) 70±1.90 96±1.92 90±2.45 73±2.72 
2 Wetting time (Sec) 63±1.86 72±1.78 70±1.53 67±2.66 
3 Wetting volume (ml) 2.9±0.554 3.5±0.95 3.4±0.846 3.2±0.22 
4 Uniformity of dispersion Pass Pass Pass Pass 
 *n=3, Data presented as mean±SD.  
 
Taste evaluation of dispersible tablet 
Sensory evaluation of dispersible tablets of optimized formulation 
batch F1 was done by a human volunteer panel of nine members. 
From sensory evaluation data bitterness value scores 1.33 which is 
close to level of bitterness 1 that is palatable. Bitterness value near 
to 1 indicates that F1 formulation was taste masked dispersible 
formulation and it confirms the taste masking efficiency of polymer. 
As compared to drug polymer dispersion F1 formulation shows less 
bitterness because of ingredients were used in tablet 
preparationsuch as mannitol, flavors etc. Sensory evaluation data 
are shown in table 4 [18, 26, 28-29]. 
 
Table 4: Sensory evaluation of F1 dispersible tablet formulation 
Sample name Scores of drug: polymer dispersion Average bitterness value 
Group II Group I Group III 
Pure drug tablet 5 5 5 5 5 5 5 5 5 5 
Optimized F1 formulation 1 2 1 1 2 1 1 1 2 1.33 
 
Release rate study of the formulation 
The optimized formulation F1 shows no drug release in phosphate 
buffer pH 6.8 compared with that of pure drugs. The polymer does 
not get solubilized in pH above 6.8 simulated salivary pH, which 
confirms taste masking of artemether. The increase in dissolution 
profile was observed when drug release of formulation F1 was 
compared with that of pure drugs. Which confirms that polymer 
release drug when it came in contact with gastric fluid pH 0.1 N HCl. 
Percent cumulative release in 0.1 N HCL was shown in fig. 5 [26-29]. 
 
 
Fig. 5: Percent cumulative drug release of formulation F1 in 0.1 N HCl (n=3, Data presented as mean±SD) 
 
CONCLUSION 
It may be concluded that kollicoatsmartseal 30D could mask the taste 
of the drug in salivary pH and shows drug release at gastric pH which 
confirms its efficiency for taste masking. From previous studies of 
taste masking, it is assumed that coating of the bitter drugs with a 
suitable polymer with no effect on drug release can mask the bitter 
taste of the drug. Hence an attempt was made to formulate taste-
masked formulation of artemether with kollicoatsmartseal 30 D as a 
coating polymer. The polymer shows no drug release at salivary pH 
and it dissolves under protonation in acidic media below pH 5.5. As 
the amount of polymer increases the taste masking efficiency also 
increases and it was confirmed by sensory evaluation method.  
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